Defense Health Agency Contracting Activity - DHACA
DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award
DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award is a funding opportunity from Defense Health Agency Contracting Activity - DHACA, closing October 22, 2026.
Overview
Summary: The intent of the fiscal year 2026 (FY26) Tick-Borne Disease Research Program (TBDRP) Therapeutic/Diagnostic Research Award (TDRA) is to support product-driven therapeutic and diagnostic development research aimed at reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and…